| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.17▲ | 7.13▲ | 7.01▲ | 6.72▲ | 6.22▲ |
| MA10 | 7.17▲ | 6.96▲ | 6.89▲ | 6.47▲ | 6.30▲ |
| MA20 | 7.14▲ | 6.86▲ | 6.71▲ | 6.16▲ | 6.39▲ |
| MA50 | 6.96▲ | 6.62▲ | 6.48▲ | 6.28▲ | 5.95▲ |
| MA100 | 6.85▲ | 6.45▲ | 6.32▲ | 6.42▲ | 6.77▲ |
| MA200 | 6.64▲ | 6.27▲ | 6.33▲ | 6.03▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.011▼ | 0.033▲ | 0.044▲ | 0.104▲ | 0.040▲ |
| RSI | 59.101▲ | 76.445▲ | 77.255▲ | 63.660▲ | 57.591▲ |
| STOCH | 55.694 | 81.642▲ | 77.500 | 82.947▲ | 61.777 |
| WILL %R | -37.500 | -5.607▲ | -4.317▲ | -2.206▲ | -6.202▲ |
| CCI | -0.501 | 114.552▲ | 173.246▲ | 242.489▲ | 151.589▲ |
|
Thursday, May 01, 2025 05:40 AM
Pinnacle West Capital reports 2025 first-quarter financial results that are in line with company’s expectations.
|
|
Thursday, April 24, 2025 05:00 PM
April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a ... Seeking to Remove Convertible Preferred Stock Exchange Cap to Permit Potential Conversion ...
|
|
Tuesday, April 22, 2025 04:20 AM
Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/05/25 | 7.04 | 7.21 | 6.99 | 7.18 | 125,757 |
| 01/05/25 | 6.89 | 7.00 | 6.62 | 6.83 | 326,272 |
| 30/04/25 | 6.26 | 6.83 | 6.102 | 6.76 | 450,597 |
| 29/04/25 | 6.42 | 6.445 | 6.33 | 6.36 | 77,190 |
| 28/04/25 | 6.41 | 6.58 | 6.32 | 6.455 | 143,955 |
| 25/04/25 | 6.10 | 6.40 | 6.10 | 6.38 | 155,733 |
| 24/04/25 | 6.34 | 6.40 | 6.15 | 6.17 | 79,547 |
| 23/04/25 | 6.38 | 6.4949 | 6.21 | 6.34 | 152,978 |
| 22/04/25 | 6.14 | 6.19 | 5.92 | 6.18 | 125,488 |
| 21/04/25 | 6.33 | 6.397 | 5.96 | 6.04 | 166,137 |
|
|
||||
|
|
||||
|
|